Results 221 to 230 of about 253,218 (253)

Cardiomyopathy of Duchenne muscular dystrophy

Pediatric Cardiology, 1988
A total of 18 male patients with Duchenne muscular dystrophy (DMD), aged 8-29 years (mean, 15.7 years), were prospectively studied to assess the cardiomyopathy associated with DMD, using clinical parameters and noninvasive cardiovascular investigations: electrocardiogram (ECG), Holter monitoring, and echocardiography.
L, D'Orsogna, J P, O'Shea, G, Miller
openaire   +2 more sources

CRISPR-Editing Therapy for Duchenne Muscular Dystrophy

Human Gene Therapy, 2023
Rhonda Bassel-Duby, Francesco Chemello
exaly  

The Immune System in Duchenne Muscular Dystrophy Pathogenesis

Biomedicines, 2021
Yvan Torrente, Chiara Villa, Andrea Farini   +2 more
exaly  

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update

Genes, 2020
Zhitao Su, Zheng Zhang, Chengmei Sun
exaly  

Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)

Journal of Pediatrics, 2009
Paul Romitti, Timothy Miller, Emma Ciafaloni   +2 more
exaly  

Prevention of Pulmonary Morbidity for Patients With Duchenne Muscular Dystrophy

Chest, 1997
Yuka Ishikawa, John Bach, Heakyung Kim   +2 more
exaly  

Duchenne Muscular Dystrophy

Pediatrics In Review, 2006
openaire   +2 more sources

miRNAs as serum biomarkers for Duchenne muscular dystrophy

EMBO Molecular Medicine, 2011
Julie Martone, Enrico Bertini, Irène Bozzoni   +2 more
exaly  

Steroids in Duchenne muscular dystrophy

Neuromuscular Disorders, 2013
V, Ricotti, D A, Ridout, F, Muntoni
openaire   +2 more sources

Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary

American Journal of Respiratory and Critical Care Medicine, 2017
David Birnkrant, Hemant Sawnani, Erik Henricson   +2 more
exaly